During the past decade, Silicon Valley Medical Imaging conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Silicon Valley Medical Imaging" are "Coronary Artery Disease (CAD)" (1 trials) and "Ischemia" (1 trials). Many other conditions were trialed in "Silicon Valley Medical Imaging" in a lesser frequency.

Most popular intervention types in "Silicon Valley Medical Imaging" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS747158" (1 trials), "Regadenoson" (1 trials) and "Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Silicon Valley Medical Imaging" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Silicon Valley Medical Imaging". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Silicon Valley Medical Imaging, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Silicon Valley Medical Imaging, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".